27.10.2017 15:36:17
|
DGAP-Ad hoc: Softing AG
DGAP-Ad-hoc: Softing AG / Key word(s): Profit Warning SOFTING AG previously forecast EBIT of slightly more than EUR 5 million for the 2017 financial year. SOFTING adjusts its expected EBIT to a figure of between EUR 2 and 2.5 million. Revenue developed largely as expected during the first nine months of 2017. A subsidiary that works for a major international automation electronics manufacturer communicated to SOFTING that a payment of just under EUR 2 million for development costs expected this year will be delayed beyond the end of the year. As things stand, this payment for a newly developed product is expected to be made in full or in parts in 2018. Additional portions of the payment are expected to be made together with product deliveries in 2018. Furthermore, the considerable foreign currency translation effects seen in the balance sheet as a result of the development of the Euro-US Dollar exchange rate will have a negative impact on earnings for the year. This impact could add up to EUR 1 million by the end of this year. Despite its positive performance seen and expected in the fourth quarter 2017, SOFTING does not expect being able to compensate for the negative factors described above. The Executive Board
27-Oct-2017 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Softing AG |
Richard-Reitzner-Allee 6 | |
85540 Haar | |
Germany | |
Phone: | +49 (0)89 456 56-333 |
Fax: | +49 (0)89 456 56-399 |
E-mail: | InvestorRelations@softing.com |
Internet: | www.softing.com |
ISIN: | DE0005178008 |
WKN: | 517800 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
End of Announcement | DGAP News Service |
|
623445 27-Oct-2017 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Softing AGmehr Nachrichten
23.12.24 |
EQS-DD: Softing AG: Dr. Wolfgang Trier, buy (EQS Group) | |
23.12.24 |
EQS-DD: Softing AG: Dr. Wolfgang Trier, Kauf (EQS Group) | |
20.12.24 |
EQS-DD: Softing AG: Dr. Wolfgang Trier, Kauf (EQS Group) | |
20.12.24 |
EQS-DD: Softing AG: Dr. Wolfgang Trier, buy (EQS Group) | |
19.12.24 |
EQS-PVR: Softing AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung (EQS Group) | |
18.12.24 |
EQS-DD: Softing AG: Dr. Wolfgang Trier, Kauf (EQS Group) | |
18.12.24 |
EQS-DD: Softing AG: Dr. Wolfgang Trier, buy (EQS Group) | |
12.12.24 |
EQS-Adhoc: Softing AG Revises Full-Year Guidance (EQS Group) |
Analysen zu Softing AGmehr Analysen
Aktien in diesem Artikel
Softing AG | 3,42 | 4,91% |
|